Boehringer Ingelheim’s Nerandomilast Filing Accepted for Review in Progressive Pulmonary Fibrosis
Boehringer Ingelheim announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products...
Novartis’ Kisqali Receives NMPA Approval for High-Risk Early Breast Cancer
Switzerland-based Novartis (NYSE: NVS) announced this week that it has received another indication approval from...
MGI Tech Partners with Genoks to Enhance Clinical Testing Services in Türkiye
China-based gene sequencing specialist MGI Tech Co., Ltd. (SHA: 688114) has entered into a strategic...
Jiangsu Hengrui Pharmaceuticals Launches Hong Kong IPO of H-Shares
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has officially launched an initial public offering...
CSPC Pharma Licenses Irinotecan Liposome Injection to Cipla for US Market
China-based CSPC Pharmaceutical Group Ltd. (HKG: 1093) has entered into a licensing agreement with India-headquartered...
WuHan Hamilton Biotech’s HUC-MSCs Product Approved for Clinical Trials in Premature Ovarian Failure
China-based WuHan Hamilton Biotechnology Co., Ltd. has announced receiving clinical trial approval from the National...
AbbVie Pays $335 Million Upfront to ADARx for Next-Gen siRNA Therapeutics
US-based pharma giant AbbVie (NYSE: ABBV) has entered into a significant collaboration with ADARx Pharmaceuticals,...
Roche’s VENTANA MET (SP44) RxDx Assay Gains FDA Approval for NSQ-NSCLC Patients
Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced that the FDA has approved the VENTANA®...
Novo Nordisk and Septerna Ink $2.2 Billion Deal for GPCR Drug Discovery
Denmark-based Novo Nordisk (NYSE: NVO, CPH: NOVO-B) and Septerna, Inc. (NASDAQ: SEPN) announced an exclusive...
Sanofi Announces $20 Billion Investment in US R&D and Manufacturing by 2030
French pharmaceutical giant Sanofi (NASDAQ: SNY) has announced its intention to invest at least $20...
GSK Signs Deal to Acquire Boston Pharmaceuticals’ Efimosfermin Alpha
UK-based pharmaceutical giant GlaxoSmithKline (GSK, NYSE: GSK) has entered into an agreement to acquire BP...
Acchrom Technologies Secures Pre-Series B Funding to Expand Chromatography Solutions
Beijing-based Acchrom Technologies Co., Ltd., a specialist in chromatography, has reportedly secured over RMB 100...
Ningbo Jansen Files STAR IPO for MRI Technology Expansion
China-based Ningbo Jansen NMR Technology Co., Ltd. announced that its initial public offering (IPO) filing...
China’s Q1 2025 Pharmaceutical Exports Rise 4.39% Despite Import Decline
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Porton Pharma Collaborates with Henan Hualong for MATC Therapy Development
China-based Contract Development and Manufacturing Organization (CDMO) Porton Pharma Solutions Ltd has entered into a...
Bayer Reports Flat Q1 Revenue amid Crop Science Decline
German pharmaceutical and chemical giant Bayer (ETR: BAYN) released its Q1 2025 financial report, recording...
Medilink Therapeutics Gains FDA IND Approval for VEGF-Targeted ADC YL242
Suzhou-based Medilink Therapeutics announced that it has received Investigational New Drug (IND) approval from the...
Zhongsheng Pharma’s Anruiwei Shows Promising Results in Pediatric Influenza A Study
China-based Guangdong Zhongsheng Pharmaceutical Co., Ltd (SHE: 002317) announced the topline analysis data from the...
Sinovac Biotech Gains Hong Kong Approval for Influenza Vaccines
China-based Sinovac Biotech Ltd (NASDAQ: SVA) announced that it has received marketing approvals from the...
InnoCare Pharma Reports 129.92% Revenue Surge in Q1 2025, Turns Profitable
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) released its Q1 2025 financial report, recording...